<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35076368</PMID><DateCompleted><Year>2022</Year><Month>01</Month><Day>28</Day></DateCompleted><DateRevised><Year>2022</Year><Month>02</Month><Day>08</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1080-6059</ISSN><JournalIssue CitedMedium="Internet"><Volume>28</Volume><Issue>2</Issue><PubDate><Year>2022</Year><Month>Feb</Month></PubDate></JournalIssue><Title>Emerging infectious diseases</Title><ISOAbbreviation>Emerg Infect Dis</ISOAbbreviation></Journal><ArticleTitle>Comparison of Complications after Coronavirus Disease and Seasonal Influenza, South Korea.</ArticleTitle><Pagination><StartPage>347</StartPage><EndPage>353</EndPage><MedlinePgn>347-353</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.3201/eid2802.211848</ELocationID><Abstract><AbstractText>We conducted a retrospective cohort study using claims data to determine the number and types of complications from coronavirus disease (COVID-19) that patients experience and which patients are more vulnerable to those complications compared with complications in patients with influenza. Among the cohort, 19.6% of COVID-19 patients and 28.5% of influenza patients had &gt;1 new complication. In most complications, COVID-19 patients had lower or similar relative risk compared with influenza patients; exceptions were hair loss, heart failure, mood disorder, and dementia. Young to middle-aged adult COVID-19 patients and patients in COVID-19 hotspots had a higher risk for complications. Overall, COVID-19 patients had fewer complications than influenza patients, but caution is necessary in high-risk groups. If the fatality rate for COVID-19 is reduced through vaccination, management strategies for this disease could be adapted, similar to those for influenza management, such as easing restrictions on economic activity or requirements for close-contact isolation.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Hyejin</ForeName><Initials>H</Initials></Author><Author ValidYN="Y"><LastName>Sung</LastName><ForeName>Ho Kyung</ForeName><Initials>HK</Initials></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Dokyoung</ForeName><Initials>D</Initials></Author><Author ValidYN="Y"><LastName>Choi</LastName><ForeName>Yeonmi</ForeName><Initials>Y</Initials></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Ji Yoon</ForeName><Initials>JY</Initials></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Jin Yong</ForeName><Initials>JY</Initials></Author><Author ValidYN="Y"><LastName>Oh</LastName><ForeName>Myoung-Don</ForeName><Initials>MD</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Emerg Infect Dis</MedlineTA><NlmUniqueID>9508155</NlmUniqueID><ISSNLinking>1080-6040</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007251" MajorTopicYN="Y">Influenza, Human</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012621" MajorTopicYN="N">Seasons</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Choi Y</Keyword><Keyword MajorTopicYN="N">Lee D</Keyword><Keyword MajorTopicYN="N">Lee JY</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">South Korea. Emerg Infect Dis. 2022 Feb [date cited]. https://doi.org/10.3201/eid2802.211848</Keyword><Keyword MajorTopicYN="N">Suggested citation for this article: Lee H</Keyword><Keyword MajorTopicYN="N">Sung HK</Keyword><Keyword MajorTopicYN="N">complications</Keyword><Keyword MajorTopicYN="N">coronavirus disease</Keyword><Keyword MajorTopicYN="N">et al. Comparison of complications after coronavirus disease and seasonal influenza</Keyword><Keyword MajorTopicYN="N">influenza</Keyword><Keyword MajorTopicYN="N">long COVID</Keyword><Keyword MajorTopicYN="N">respiratory infections</Keyword><Keyword MajorTopicYN="N">severe acute respiratory syndrome coronavirus 2</Keyword><Keyword MajorTopicYN="N">viruses</Keyword><Keyword MajorTopicYN="N">zoonoses</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>1</Month><Day>25</Day><Hour>12</Hour><Minute>19</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>1</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>1</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>2</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35076368</ArticleId><ArticleId IdType="pmc">PMC8798693</ArticleId><ArticleId IdType="doi">10.3201/eid2802.211848</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Del Rio C, Collins LF, Malani P. Long-term health consequences of COVID-19. JAMA. 2020;324:1723&#x2013;4. 10.1001/jama.2020.19719</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.19719</ArticleId><ArticleId IdType="pmc">PMC8019677</ArticleId><ArticleId IdType="pubmed">33031513</ArticleId></ArticleIdList></Reference><Reference><Citation>Fraser E. Long term respiratory complications of covid-19. BMJ. 2020;370:m3001. 10.1136/bmj.m3001</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.m3001</ArticleId><ArticleId IdType="pubmed">32747332</ArticleId></ArticleIdList></Reference><Reference><Citation>Carf&#xec; A, Bernabei R, Landi F; Gemelli Against COVID-19 Post-Acute Care Study Group. Gemelli against COVID-19 Post-Acute Care Study Group. Persistent symptoms in patients after acute COVID-19. JAMA. 2020;324:603&#x2013;5. 10.1001/jama.2020.12603</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.12603</ArticleId><ArticleId IdType="pmc">PMC7349096</ArticleId><ArticleId IdType="pubmed">32644129</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang F, Kream RM, Stefano GB. Long-term respiratory and neurological sequelae of COVID-19. Med Sci Monit. 2020;26:e928996. 10.12659/MSM.928996</Citation><ArticleIdList><ArticleId IdType="doi">10.12659/MSM.928996</ArticleId><ArticleId IdType="pmc">PMC7643287</ArticleId><ArticleId IdType="pubmed">33177481</ArticleId></ArticleIdList></Reference><Reference><Citation>Whitcroft KL, Hummel T. Olfactory dysfunction in COVID-19. JAMA. 2020;323:2512&#x2013;4. 10.1001/jama.2020.8391</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.8391</ArticleId><ArticleId IdType="pubmed">32432682</ArticleId></ArticleIdList></Reference><Reference><Citation>Ellul MA, Benjamin L, Singh B, Lant S, Michael BD, Easton A, et al. Neurological associations of COVID-19. Lancet Neurol. 2020;19:767&#x2013;83. 10.1016/S1474-4422(20)30221-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(20)30221-0</ArticleId><ArticleId IdType="pmc">PMC7332267</ArticleId><ArticleId IdType="pubmed">32622375</ArticleId></ArticleIdList></Reference><Reference><Citation>Miners S, Kehoe PG, Love S. Cognitive impact of COVID-19: looking beyond the short term. Alzheimers Res Ther. 2020;12:170. 10.1186/s13195-020-00744-w</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13195-020-00744-w</ArticleId><ArticleId IdType="pmc">PMC7772800</ArticleId><ArticleId IdType="pubmed">33380345</ArticleId></ArticleIdList></Reference><Reference><Citation>Sivan M, Taylor S. NICE guideline on long covid. BMJ. 2020;371:m4938. 10.1136/bmj.m4938</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.m4938</ArticleId><ArticleId IdType="pubmed">33361141</ArticleId></ArticleIdList></Reference><Reference><Citation>Piroth L, Cottenet J, Mariet A-S, Bonniaud P, Blot M, Tubert-Bitter P, et al. Comparison of the characteristics, morbidity, and mortality of COVID-19 and seasonal influenza: a nationwide, population-based retrospective cohort study. Lancet Respir Med. 2021;9:251&#x2013;9. 10.1016/S2213-2600(20)30527-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(20)30527-0</ArticleId><ArticleId IdType="pmc">PMC7832247</ArticleId><ArticleId IdType="pubmed">33341155</ArticleId></ArticleIdList></Reference><Reference><Citation>National Health Insurance Service. 2018 Medical Aid statistics. 2019. [cited 2021 Dec 20]. https://www.hira.or.kr/bbsDummy.do?pgmid=HIRAA020045010000&amp;brdScnBltNo=4&amp;brdBltNo=2318</Citation></Reference><Reference><Citation>Centers for Disease Control and Prevention (CDC). Influenza activity&#x2014;United States, 2012-13 season and composition of the 2013-14 influenza vaccine. MMWR Morb Mortal Wkly Rep. 2013;62:473&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4604847</ArticleId><ArticleId IdType="pubmed">23760189</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization. R&amp;D blueprint and COVID-19. 2020.  [cited 2021 Dec 2]. https://www.who.int/teams/blueprint/covid-19</Citation></Reference><Reference><Citation>Marshall JC, Murthy S, Diaz J, Adhikari NK, Angus DC, Arabi YM, et al. WHO Working Group on the Clinical Characterisation and Management of COVID-19 infection. A minimal common outcome measure set for COVID-19 clinical research. Lancet Infect Dis. 2020;20:e192&#x2013;7. 10.1016/S1473-3099(20)30483-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(20)30483-7</ArticleId><ArticleId IdType="pmc">PMC7292605</ArticleId><ArticleId IdType="pubmed">32539990</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiong Q, Xu M, Li J, Liu Y, Zhang J, Xu Y, et al. Clinical sequelae of COVID-19 survivors in Wuhan, China: a single-centre longitudinal study. Clin Microbiol Infect. 2021;27:89&#x2013;95. 10.1016/j.cmi.2020.09.023</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmi.2020.09.023</ArticleId><ArticleId IdType="pmc">PMC7510771</ArticleId><ArticleId IdType="pubmed">32979574</ArticleId></ArticleIdList></Reference><Reference><Citation>Mandal S, Barnett J, Brill SE, Brown JS, Denneny EK, Hare SS, et al.; ARC Study Group. &#x2018;Long-COVID&#x2019;: a cross-sectional study of persisting symptoms, biomarker and imaging abnormalities following hospitalisation for COVID-19. Thorax. 2021;76:396&#x2013;8. 10.1136/thoraxjnl-2020-215818</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/thoraxjnl-2020-215818</ArticleId><ArticleId IdType="pmc">PMC7615158</ArticleId><ArticleId IdType="pubmed">33172844</ArticleId></ArticleIdList></Reference><Reference><Citation>Wambier CG, Va&#xf1;o-Galv&#xe1;n S, McCoy J, Gomez-Zubiaur A, Herrera S, Hermosa-Gelbard &#xc1;, et al. Androgenetic alopecia present in the majority of patients hospitalized with COVID-19: The &#x201c;Gabrin sign&#x201d;. J Am Acad Dermatol. 2020;83:680&#x2013;2. 10.1016/j.jaad.2020.05.079</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaad.2020.05.079</ArticleId><ArticleId IdType="pmc">PMC7242206</ArticleId><ArticleId IdType="pubmed">32446821</ArticleId></ArticleIdList></Reference><Reference><Citation>Leung TYM, Chan AYL, Chan EW, Chan VKY, Chui CSL, Cowling BJ, et al. Short- and potential long-term adverse health outcomes of COVID-19: a rapid review. Emerg Microbes Infect. 2020;9:2190&#x2013;9. 10.1080/22221751.2020.1825914</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/22221751.2020.1825914</ArticleId><ArticleId IdType="pmc">PMC7586446</ArticleId><ArticleId IdType="pubmed">32940572</ArticleId></ArticleIdList></Reference><Reference><Citation>Varatharaj A, Thomas N, Ellul MA, Davies NWS, Pollak TA, Tenorio EL, et al.; CoroNerve Study Group. Neurological and neuropsychiatric complications of COVID-19 in 153 patients: a UK-wide surveillance study. Lancet Psychiatry. 2020;7:875&#x2013;82. 10.1016/S2215-0366(20)30287-X</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2215-0366(20)30287-X</ArticleId><ArticleId IdType="pmc">PMC7316461</ArticleId><ArticleId IdType="pubmed">32593341</ArticleId></ArticleIdList></Reference><Reference><Citation>Gorna R, MacDermott N, Rayner C, O&#x2019;Hara M, Evans S, Agyen L, et al. Long COVID guidelines need to reflect lived experience. Lancet. 2021;397:455&#x2013;7. 10.1016/S0140-6736(20)32705-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)32705-7</ArticleId><ArticleId IdType="pmc">PMC7755576</ArticleId><ArticleId IdType="pubmed">33357467</ArticleId></ArticleIdList></Reference><Reference><Citation>Yelin D, Wirtheim E, Vetter P, Kalil AC, Bruchfeld J, Runold M, et al. Long-term consequences of COVID-19: research needs. Lancet Infect Dis. 2020;20:1115&#x2013;7. 10.1016/S1473-3099(20)30701-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(20)30701-5</ArticleId><ArticleId IdType="pmc">PMC7462626</ArticleId><ArticleId IdType="pubmed">32888409</ArticleId></ArticleIdList></Reference><Reference><Citation>Michelen M, Manoharan L, Elkheir N, Cheng V, Dagens A, Hastie C, et al. Characterising long COVID: a living systematic review. BMJ Glob Health. 2021;6:e005427. 10.1136/bmjgh-2021-005427</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjgh-2021-005427</ArticleId><ArticleId IdType="pmc">PMC8478580</ArticleId><ArticleId IdType="pubmed">34580069</ArticleId></ArticleIdList></Reference><Reference><Citation>Khan MS, Shahid I, Anker SD, Solomon SD, Vardeny O, Michos ED, et al. Cardiovascular implications of COVID-19 versus influenza infection: a review. BMC Med. 2020;18:403. 10.1186/s12916-020-01816-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12916-020-01816-2</ArticleId><ArticleId IdType="pmc">PMC7746485</ArticleId><ArticleId IdType="pubmed">33334360</ArticleId></ArticleIdList></Reference><Reference><Citation>Shchendrygina A, Nagel E, Puntmann VO, Valbuena-Lopez S. COVID-19 myocarditis and prospective heart failure burden. Expert Rev Cardiovasc Ther. 2021;19:5&#x2013;14. 10.1080/14779072.2021.1844005</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/14779072.2021.1844005</ArticleId><ArticleId IdType="pubmed">33119418</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang DH, McCoy RG. Planning for the post-COVID syndrome: how payers can mitigate long-term complications of the pandemic. J Gen Intern Med. 2020;35:3036&#x2013;9. 10.1007/s11606-020-06042-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11606-020-06042-3</ArticleId><ArticleId IdType="pmc">PMC7375754</ArticleId><ArticleId IdType="pubmed">32700223</ArticleId></ArticleIdList></Reference><Reference><Citation>Becker RC. Anticipating the long-term cardiovascular effects of COVID-19. J Thromb Thrombolysis. 2020;50:512&#x2013;24. 10.1007/s11239-020-02266-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11239-020-02266-6</ArticleId><ArticleId IdType="pmc">PMC7467860</ArticleId><ArticleId IdType="pubmed">32880795</ArticleId></ArticleIdList></Reference><Reference><Citation>Simard J, Volicer L. Loneliness and isolation in long-term care and the COVID-19 pandemic. J Am Med Dir Assoc. 2020;21:966&#x2013;7. 10.1016/j.jamda.2020.05.006</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jamda.2020.05.006</ArticleId><ArticleId IdType="pmc">PMC7205644</ArticleId><ArticleId IdType="pubmed">32505516</ArticleId></ArticleIdList></Reference><Reference><Citation>Jackson SE, Garnett C, Shahab L, Oldham M, Brown J. Association of the COVID-19 lockdown with smoking, drinking and attempts to quit in England: an analysis of 2019-20 data. Addiction. 2021;116:1233&#x2013;44. 10.1111/add.15295</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/add.15295</ArticleId><ArticleId IdType="pmc">PMC8436745</ArticleId><ArticleId IdType="pubmed">33089562</ArticleId></ArticleIdList></Reference><Reference><Citation>Jacob L, Smith L, Armstrong NC, Yakkundi A, Barnett Y, Butler L, et al. Alcohol use and mental health during COVID-19 lockdown: A cross-sectional study in a sample of UK adults. Drug Alcohol Depend. 2021;219:108488. 10.1016/j.drugalcdep.2020.108488</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.drugalcdep.2020.108488</ArticleId><ArticleId IdType="pmc">PMC7768217</ArticleId><ArticleId IdType="pubmed">33383352</ArticleId></ArticleIdList></Reference><Reference><Citation>Vanderbruggen N, Matthys F, Van Laere S, Zeeuws D, Santermans L, Van den Ameele S, et al. Self-reported alcohol, tobacco, and cannabis use during COVID-19 lockdown measures: results from a web-based survey. Eur Addict Res. 2020;26:309&#x2013;15. 10.1159/000510822</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000510822</ArticleId><ArticleId IdType="pmc">PMC7573904</ArticleId><ArticleId IdType="pubmed">32961535</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C, Huang L, Wang Y, Li X, Ren L, Gu X, et al. 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. Lancet. 2021;397:220&#x2013;32. 10.1016/S0140-6736(20)32656-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)32656-8</ArticleId><ArticleId IdType="pmc">PMC7833295</ArticleId><ArticleId IdType="pubmed">33428867</ArticleId></ArticleIdList></Reference><Reference><Citation>Moradi F, Enjezab B, Ghadiri-Anari A. The role of androgens in COVID-19. Diabetes Metab Syndr. 2020;14:2003&#x2013;6. 10.1016/j.dsx.2020.10.014</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.dsx.2020.10.014</ArticleId><ArticleId IdType="pmc">PMC7557269</ArticleId><ArticleId IdType="pubmed">33091758</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee H, Lee JR, Jung H, Lee JY. Power of universal health coverage in the era of COVID-19: A nationwide observational study. Lancet Reg Health West Pac. 2021;7:100088. 10.1016/j.lanwpc.2020.100088</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lanwpc.2020.100088</ArticleId><ArticleId IdType="pmc">PMC7826087</ArticleId><ArticleId IdType="pubmed">33521744</ArticleId></ArticleIdList></Reference><Reference><Citation>Park Y, Huh IS, Lee J, Kang CR, Cho SI, Ham HJ, et al.; Seoul Metropolitan Government COVID-19 Rapid Response (SCoRR) Team. (SCoRR) Team. Application of testing-tracing-treatment strategy in response to the COVID-19 outbreak in Seoul, Korea. J Korean Med Sci. 2020;35:e396. 10.3346/jkms.2020.35.e396</Citation><ArticleIdList><ArticleId IdType="doi">10.3346/jkms.2020.35.e396</ArticleId><ArticleId IdType="pmc">PMC7683243</ArticleId><ArticleId IdType="pubmed">33230987</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>